Moise Danielpour, MD, is one of the few pediatric neurosurgeons in the world with experience with in utero surgical treatment for birth defects, such as myelomeningocele. He is a member of the international prenatal neurology and neurosurgery conference team as well as a member of the Cedars-Sinai International Skeletal Dysplasia Program. He is a world-renowned investigator and neurosurgical expert on Congenital Malformations of the Central Nervous System and acquired neurosurgical diseases such as Skeletal Dysplasia, Hydrocephalus, Chiari Malformations, brain tumors, Craniosynostosis and Vascular Malformations. Danielpour is also an expert in the use of minimally invasive surgical technology in the care of children with central nervous system disease. His expertise includes the use of minimally invasive techniques in the treatment of pediatric hydrocephalus (endoscopic third ventriculostomy, aquaductoplasty and endoscopic fenestration of intracranial cysts), specifically in neonates and children. In the laboratory, Danielpour seeks to discover the mechanisms regulating the pathological differentiation of neural stem cells into brain tumor progenitors. Using a next generation glioma models created by him and his colleague, Dr. Joshua Breunig, they introduce patient-specific mutations to create analogous tumors in animal models. From these cancer cells, they are uncovering the developmental origins of tumorigenesis and have begun researching new, more targeted treatments to halt the progression of these malignancies. Dr. Danielpour also investigates the molecular control of neural stem cell behavior in the brain, seeking to replace specific population of glia lost after intraventricular hemorrhage of prematurity.